HIGHLIGHTS
- who: Mohammed A. Muzaffer from the (UNIVERSITY) have published the Article: Tocilizumab in management of refractory juvenile idiopathic arthritis, 10u2009years of experience at tertiary university hospital, in the Journal: (JOURNAL)
- what: The authors aimed to determine the efficacy and safety of tocilizumab (TCZ) in the management of systemic (sJIA) and polyarticular (pJIA) in children who are resistant to conventional as well as other biological therapies.
- how: The research was conducted in compliance with the values of the Helsinki Declaration. Data were analyzed using the statistical package for the Social Sciences (SPSS) version 25 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.